Boston Scientific (NYSE:BSX – Get Free Report) had its price target boosted by analysts at Morgan Stanley from $92.00 to $100 ...

BofA raised the firm’s price target on Boston Scientific (BSX) to $100 from $90 and keeps a Buy rating on the shares. The ...

Wave Life Sciences (NASDAQ:WVE – Get Free Report) had its target price hoisted by Royal Bank of Canada from $7.00 to $15.00 in a research note issued on Monday, Benzinga reports. The firm currently ...

OALC is a Christian faith-based alternative to S&P 500 Index funds. Check out OALC's diversification, risk, growth, value, ...

However, the Financial Times reported on September 26 that Saudi Arabia is ready to abandon its unofficial oil price target of $100 a barrel to regain its market share and is committed to ...

We maintain HOLD recommendation with a revised target price of Rs 5,026 (previously Rs 5,098), as we roll forward to FY27 based on 45 times EV/Ebitda(implying 70x FY27E EPS)," Antique Stock ...

For more than two years now, higher prices have been pinching consumers’ wallets and testing their patience — but there’s at least one part of their monthly budget that has more breathing ...

The U.S. central bank tracks the PCE price indexes for its 2% inflation target. "We anticipate a more modest 25 basis points reduction next month," said Paul Ashworth, chief North America ...

Kotak Institutional Equities has a 'buy' rating on the stock with a target price of Rs 250. Nirmal Bang and Nuvama Institutional Equities have a 'hold' rating on Bandhan Bank with target prices of ...

JP Morgan has also revised Vodafone Idea share target price to Rs 10 from Rs 7, implying an 8.8-per cent upside from the stock's last closing price of Rs 9.19 per share on the BSE. This target price ...

Therefore, holding above $138 seems crucial for an early bail-out and a refocus on the pattern’s upper resistance. Upon a breakout of this pattern, eyes will be set on new all-time highs with a price ...

Peter A. Coclanis does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...